Translational Research in Lung Biology and Disease
Translational Research in Lung Biology and Disease
批准号:
9333156
负责人:
Charles G Irvin
金额:
$40.46万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-15 至 2018-06-30
关键词:
AddressAgeAnimalsApplications GrantsAsthmaBiologyCause of DeathCellular biologyCenters of Research ExcellenceCessation of lifeClinical ResearchConsultationsCystic FibrosisDevelopmentDiagnosisDiseaseDoctor of PhilosophyEnvironmentEpithelial CellsExtramural ActivitiesFundingGap JunctionsGoalsInterdisciplinary StudyLungLung InflammationLung diseasesMedicineMentorsMethodsMolecularMorbidity - disease ratePathogenesisPeer ReviewPhasePhenotypePhysiologyProductivityPublicationsResearchResearch PersonnelResearch SupportScience of geneticsScientistSocietiesTrainingTransgenic OrganismsTranslational ResearchUnited StatesUniversitiesVermontcareercareer developmentclinical investigationcollegeknockout animalmortalityprogramsresearch and developmentsuccess
中文摘要
在美国,肺部疾病是导致发病率和死亡率的重要原因。虽然所有其他主要死亡原因都在减少,但经年龄调整后的肺部疾病死亡率继续上升。Cobre第三阶段续签申请的总体目的是继续发展佛蒙特大学医学院佛蒙特州肺脏中心(VLC)的肺生物学和疾病研究计划。VLC项目的核心是卓越。科学优势包括呼吸道上皮细胞生物学、囊性纤维化、哮喘炎症、肺生理学、转译动物研究以及肺部疾病发病机制的临床研究。在上一个供资周期中,我们继续积累了生产力的记录,包括:招聘了大量训练有素的博士和医学博士和肺科科学家,发表了影响很大的同行评议出版物,并继续增加了外部资金。
佛蒙特州肺科中心要继续取得成功,一个关键的条件是要有一个刺激的环境,在这个环境中可以实现最佳的职业发展。因此,VLC-Cobre目前的目标是:
1)发展一批有才华的医学博士和博士生物医学研究人员的职业生涯
2)就具有竞争力的科学方法提供熟练的指导和咨询
3)保持尖端的研究环境
4)开发临床研究核心,保持转基因/基因敲除动物和小动物表型核心,
这一拟议的计划将通过形成与哪个中心的联系来实现VLC的可持续性
将创建授予申请。这项提案还解决了扩大和支持
UVM的翻译性多学科研究,因为这是基础分子、细胞
基因科学被转化为新的诊断和治疗方法。
英文摘要
Lung disease is a significant cause of morbidity and mortality in the United States. While all other major causes of death are decreasing, age-adjusted mortality due to lung disease continues to rise. The overall purpose of this COBRE Phase III renewal application is to continue the development of the research program in Lung Biology and Disease at The Vermont Lung Center (VLC) of the University of Vermont College of Medicine. The keystone of the VLC program is excellence. The scientific strengths include airway epithelial cell biology, cystic fibrosis, asthma inflammation, lung physiology, translational animal studies, and clinical investigation into the pathogenesis of lung disease. In the last funding cycle we have continued to amass a record of productivity including: recruitment of a critical mass of well trained PhD and MD pulmonary scientists, high-impact peer-reviewed publications and continued as well as considerable increase in extramural funding.
A critical requirement for the continued success of the Vermont Lung Center is the stimulating environment in which optimal career development can occur. The current goals of the VLC-COBRE are therefore to:
1) Develop the careers of a group of talented MD and PhD biomedical investigators
2) Provide skilled mentoring and consultation on com petitive scientific approaches
3) Maintain a "cutting edge" research milieu
4) Develop a clinical studies core, maintain transgenic/knockout animal and small animal phenotyping core,
This proposed program will build towards sustainability of the VLC by forming the nexus from which center
grant applications will be created. This proposal also addresses the urgent need to expand and support
translational multidisciplinary research at UVM, because this is how advances in basic molecular, cellular
and genetic science are converted into new methods of diagnosis and therapy.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Modeling the impairment of airway smooth muscle force by stretch.
通过拉伸对气道平滑肌力的损伤进行建模。
DOI:
10.1152/japplphysiol.00938.2014
发表时间:
2015
期刊:
Journal of applied physiology (Bethesda, Md. : 1985)
影响因子:
--
作者:
[Bates,JasonHT]
通讯作者:
Bates,JasonHT
DOI:
10.1186/s12931-015-0303-6
发表时间:
2015-11-26
期刊:
Respiratory research
影响因子:
5.8
作者:
[Dixon AE, Subramanian M, DeSarno M, Black K, Lane L, Holguin F]
通讯作者:
Holguin F
DOI:
10.1111/cea.12506
发表时间:
2015-04
期刊:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
影响因子:
--
作者:
[Chapman DG, Irvin CG]
通讯作者:
Irvin CG
IDeA Entrepreneurship Training and Community Development
-
批准号:10703427
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2022
-
负责人:Charles G Irvin
-
依托单位:
IDeA Entrepreneurship Training and Community Development
-
批准号:10516248
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2022
-
负责人:Charles G Irvin
-
依托单位:
Deep Functional Phenotyping of the ALA Lung Health Cohort
-
批准号:10685503
-
项目类别:
-
资助金额:$69.14万
-
财政年份:2022
-
负责人:Charles G Irvin
-
依托单位:
TRANSLATIONAL RESEARCH IN LUNG BIOLOGY AND DISEASE
-
批准号:8364916
-
项目类别:
-
资助金额:$112.55万
-
财政年份:2011
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8126199
-
项目类别:
-
资助金额:$112.55万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8137515
-
项目类别:
-
资助金额:$14.24万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:7939084
-
项目类别:
-
资助金额:$113.69万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8542877
-
项目类别:
-
资助金额:$107.28万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8723247
-
项目类别:
-
资助金额:$109.31万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8138205
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8319673
-
项目类别:
-
资助金额:$113.1万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
COBRE: UVT: ADMINISTRATIVE & INTELLECTUAL & ENVIRONMENTAL
-
批准号:7959620
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2009
-
负责人:Charles G Irvin
-
依托单位:
PILOT PROJECT AND EMERGING OPPORTUNITIES
-
批准号:7959626
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2009
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology
-
批准号:7920731
-
项目类别:
-
资助金额:$45.03万
-
财政年份:2009
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology
-
批准号:7920730
-
项目类别:
-
资助金额:$19.67万
-
财政年份:2009
-
负责人:Charles G Irvin
-
依托单位:
COBRE: UVT: ADMINISTRATIVE & INTELLECTUAL & ENVIRONMENTAL
-
批准号:7720873
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2008
-
负责人:Charles G Irvin
-
依托单位:
COBRE: UVT: ADMINISTRATIVE & INTELLECTUAL & ENVIRONMENTAL
-
批准号:7609697
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2007
-
负责人:Charles G Irvin
-
依托单位:
COBRE: UVT: ADMINISTRATIVE & INTELLECTUAL & ENVIRONMENTAL
-
批准号:7381075
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2006
-
负责人:Charles G Irvin
-
依托单位:
National IDeA Symposium of Biomedical Excellence (NISBRE)
-
批准号:8209026
-
项目类别:
-
资助金额:$32.61万
-
财政年份:2005
-
负责人:Charles G Irvin
-
依托单位:
National IDeA Symposium of Biomedical Research Excellence (NISBRE)
-
批准号:7126371
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2005
-
负责人:Charles G Irvin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: